09.24.15
Crown Bioscience, a global drug discovery and development service company providing translational platforms to advance oncology and metabolic disease research, has named Severine Marrony manager, business development, in France.
Ms. Marrony has held various business development roles for global life science companies with expertise in the areas of microbiology, pharmacology, toxicology, molecular and cellular biology, and immunology. She has a Ph.D. in molecular and cellular biology, and immunology from Strasbourg University and was involved in two patents while working at Novartis. She is fluent in French, English and German.
“We are thrilled to have Severine join the Crown team,” said Laurie Heilmann, senior vice president of global strategy, marketing and business development, Crown Bioscience. “Her business development and technical expertise will support our rapid expansion in France.”
Ms. Marrony has held various business development roles for global life science companies with expertise in the areas of microbiology, pharmacology, toxicology, molecular and cellular biology, and immunology. She has a Ph.D. in molecular and cellular biology, and immunology from Strasbourg University and was involved in two patents while working at Novartis. She is fluent in French, English and German.
“We are thrilled to have Severine join the Crown team,” said Laurie Heilmann, senior vice president of global strategy, marketing and business development, Crown Bioscience. “Her business development and technical expertise will support our rapid expansion in France.”